Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study

BACKGROUND: Escitalopram is a selective serotonin reuptake inhibitor, widely used in the treatment of affective disorders. The purpose of this study was to examine its safety and tolerability, as mono- versus augmentative therapy, in a group of patients with affective disorders. MATERIALS AND METHOD...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dell’Osso, Bernardo, Arici, Chiara, Dobrea, Cristina, Camuri, Giulia, Benatti, Beatrice, Altamura, A Carlo
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2013
Témata:
Short Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3573802/
https://ncbi.nlm.nih.gov/pubmed/23429980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S39322
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky